Transcription of ICH HARMONISED TRIPARTITE GUIDELINE
{{id}} {{{paragraph}}}
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL. REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. ICH HARMONISED TRIPARTITE GUIDELINE . good MANUFACTURING PRACTICE GUIDE FOR. ACTIVE PHARMACEUTICAL INGREDIENTS. Q7. Current Step 4 version dated 10 November 2000. This GUIDELINE has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. At Step 4 of the Process the final draft is recommended for adoption to the regulatory bodies of the European Union, Japan and USA. Q7. Document History New First Codification History Date Codification November 2005. Q7A Approval by the Steering Committee under Step 2 and 19 Q7. release for public consultation. July 2000. Current Step 4 version Q7A Approval by the Steering Committee under Step 4 and 10 Q7. recommendation for adoption to the three ICH regulatory November bodies.
GOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL INGREDIENTS 1. INTRODUCTION 1.1 Objective This document (Guide) is intended to provide guidance regarding good manufacturing practice (GMP) for the manufacturing of active pharmaceutical ingredients (APIs) under an
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
GOOD PRACTICE GUIDANCE ON INTERNAL CONTROLS, Good Practice Guidance, Guidance, Good, Application of Good Distribution Practice for Medical Devices, LBMA Responsible Gold Guidance, Internal, Controls, Guide to master formulae, Guide to Master Formulae Guidance, Practice, Practice Guidance, Control Self Assessment, Good Manufacturing Practice (GMP) Printing Inks, Internal Financial Controls-IFCOR, Internal Controls